Detalhe da pesquisa
1.
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19.
J Antimicrob Chemother
; 76(7): 1874-1885, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33880524
2.
Identifying Structural Features of Nucleotide Analogues to Overcome SARS-CoV-2 Exonuclease Activity.
Viruses
; 14(7)2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35891393
3.
Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture.
Commun Biol
; 5(1): 154, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35194144
4.
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones.
Viruses
; 14(7)2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35891437
5.
Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells.
Sci Rep
; 12(1): 18506, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323770
6.
A General LC-MS-Based Method for Direct and De Novo Sequencing of RNA Mixtures Containing both Canonical and Modified Nucleotides.
Methods Mol Biol
; 2298: 261-277, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34085251
7.
Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics.
bioRxiv
; 2021 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312622
8.
Comparison of structural, functional and in vitro digestion properties of bread incorporated with grapefruit peel soluble dietary fibers prepared by three microwave-assisted modifications.
Food Funct
; 11(7): 6458-6466, 2020 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32618304
9.
Direct Sequencing of tRNA by 2D-HELS-AA MS Seq Reveals Its Different Isoforms and Dynamic Base Modifications.
ACS Chem Biol
; 15(6): 1464-1472, 2020 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32364699
10.
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz | ID: arc-54654
11.
Combination of antiviral drugs inhibits SARS-CoV- 2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz | ID: arc-53619
12.
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz | ID: arc-48250
13.
Combination of Antiviral Drugs to Inhibit SARS-CoV-2 Polymerase and Exonuclease as Potential COVID-19 Therapeutics
Não convencional
em Inglês
| Arca: Repositório institucional da Fiocruz | ID: arc-48718